These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 2551578
1. The mutagenic and immortalizing potential of polyoma virus large T antigen. Strauss M, Lübbe L, Kiessling U, Platzer M, Griffin BE. Curr Top Microbiol Immunol; 1989; 144():129-134. PubMed ID: 2551578 [No Abstract] [Full Text] [Related]
2. Studies on the polyoma virus tumor-specific transplantation antigen (TSTA). Dalianis T. Adv Cancer Res; 1990; 55():57-85. PubMed ID: 1696775 [No Abstract] [Full Text] [Related]
3. A viable mouse polyomavirus mutant without immortalizing or transforming activities. Linder S, Nilsson M, Martens I, Magnusson G. Virology; 1990 Nov; 179(1):78-86. PubMed ID: 2171224 [Abstract] [Full Text] [Related]
4. A polyomavirus tumor-specific transplantation antigen (TSTA) epitope is situated within the N-terminal amino acid sequence common to middle and small T-antigens. Reinholdsson G, Ramqvist T, Brandberg J, Dalianis T. Virology; 1988 Oct; 166(2):616-9. PubMed ID: 2459846 [Abstract] [Full Text] [Related]
5. Mutations within the hamster polyomavirus large T antigen domain involved in pRb binding impair virus productive cycle and immortalization capacity. Goutebroze L, de la Roche Saint Andre C, Scherneck S, Feunteun J. Oncogene; 1993 Mar; 8(3):685-93. PubMed ID: 8382359 [Abstract] [Full Text] [Related]
6. Cell alterations induced by the large T-antigens of SV40 and polyoma virus. Dilworth SM. Semin Cancer Biol; 1990 Dec; 1(6):407-14. PubMed ID: 1966492 [Abstract] [Full Text] [Related]
7. Viable deletion mutant in the medium and large T-antigen-coding sequences of the polyoma virus genome. Bendig MM, Thomas T, Folk WR. J Virol; 1980 Mar; 33(3):1215-20. PubMed ID: 6245272 [Abstract] [Full Text] [Related]
8. Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines. Tischler AS, Freund R, Carroll J, Cahill AL, Perlman RL, Alroy J, Riseberg JC. Lab Invest; 1993 May; 68(5):541-9. PubMed ID: 8098784 [Abstract] [Full Text] [Related]
10. Glucocorticoids facilitate the stable transformation of embryonal rat fibroblasts by a polyomavirus large tumor antigen-deficient mutant. Martens I, Nilsson M, Magnusson G, Linder S. Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5571-5. PubMed ID: 2840668 [Abstract] [Full Text] [Related]
14. Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding. Yi X, Peterson J, Freund R. J Virol; 1997 Sep; 71(9):6279-86. PubMed ID: 9261344 [Abstract] [Full Text] [Related]
15. Polyoma virus middle T antigen and its role in identifying cancer-related molecules. Dilworth SM. Nat Rev Cancer; 2002 Dec; 2(12):951-6. PubMed ID: 12459733 [Abstract] [Full Text] [Related]
17. Immunization against the polyoma tumor-specific transplantation antigen (TSTA) with polyoma T-antigens. Ramqvist T, Pallas DO, DeAnda J, Ahrlund-Richter L, Reinholdsson G, Roberts TM, Schaffhausen BS, Dalianis T. Int J Cancer; 1988 Jul 15; 42(1):123-8. PubMed ID: 2839427 [Abstract] [Full Text] [Related]
18. Cell transformation by the middle T-antigen of polyoma virus. Ichaso N, Dilworth SM. Oncogene; 2001 Nov 26; 20(54):7908-16. PubMed ID: 11753673 [Abstract] [Full Text] [Related]
19. Interactions between the middle T antigen of polyomavirus and host cell proteins. Courtneidge SA, Kypta RM, Ulug ET. Cold Spring Harb Symp Quant Biol; 1988 Nov 26; 53 Pt 1():153-60. PubMed ID: 2855479 [No Abstract] [Full Text] [Related]